Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Neurosurgery. Pediatrics|January 6, 2018
Head shape at age 36 months among children with and without a history of positional skull deformationBrent R Collett, Brian G Leroux, Erin R Wallace, et al.Plos One|April 17, 2015
Predicting addictive vulnerability: individual differences in initial responding to a drug's pharmacological effectsDouglas S Ramsay, Salwa Al-Noori, Jason Shao, et al.Journal of Medicinal Chemistry|November 3, 2016
Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine MethyltransferaseKyle V Butler, Anqi Ma, Wenyu Yu, et al.Plos One|June 17, 2020
Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin AmericaLindsay N Carpp, Youyi Fong, Matthew Bonaparte, et al.The American Journal of Tropical Medicine and Hygiene|May 23, 2019
Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody ResponsePeter B Gilbert, Ying Huang, Michal Juraska, et al.Vaccine|July 19, 2020
Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccineMarcel E Curlin, Jason Shao, Gabriela Diaz, et al.Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trialsMichal Juraska, Craig A Magaret, Jason Shao, et al.The Journal of Clinical Investigation|February 25, 2021
CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplificationAfam A Okoye, Derick D Duell, Yoshinori Fukazawa, et al.Science (New York, N.Y.)|March 26, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacyMarieke C Verweij, Scott G Hansen, Ravi Iyer, et al.Science Translational Medicine|July 19, 2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challengeScott G Hansen, Emily E Marshall, Daniel Malouli, et al.Pageof 2